Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Aduhelm (aducanumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aduhelm (aducanumab) / Neurimmune, Eisai
NCT01397539: Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Completed
1
53
US
BIIB037, Aducanumab, fully human IgG1 anti-Aβ mAb, Placebo
Biogen
Alzheimer's Disease
08/13
08/13

Download Options